Pharmaceutical companies in Nepal are allowed to make medicines only by paying royalties to innovators and without obtaining patent rights.
This flexibility is provided for least-developed countries (LDCs) like Nepal under the WTO’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
However, Nepal will lose it…